Germany Develops New Method for Producing Pharmaceutical Active Ingredient

Business News Agency August 20 News Dortmund University of Technology in Germany issued a communique on the 19th, saying that researchers at the university have developed a new method of using biological means to produce the active ingredient of medicinal cannabis, tetrahydrocannabinol.

Researchers first found genes that could promote the production of tetrahydrocannabinol in medicinal marijuana, then extracted the genes, implanted them with specific microorganisms, and then allowed these microorganisms to multiply continuously in petri dishes, eventually prompting them to produce tetrahydrogen. Cannabinol. The researchers stated that the new method is more economical and simpler than traditional tetrahydrocannabinol biosynthetic manufacturing methods.

Tetrahydrocannabinol is the main active ingredient of medicinal cannabis, which can be used in the treatment of diseases such as cancer and multiple sclerosis. In Germany, due to legal restrictions, people can only extract this substance from medicinal cannabis, which contains only 0.2% tetrahydrocannabinol, in fiber hemp. Therefore, the annual production of tetrahydrocannabinol in Germany is only 20 kg, but in Germany, The annual medical demand is more than one ton.